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Abstract Although oleate has been implicated in the regulation
of phospholipase D (PLD) activity, the molecular identity of the
oleate-stimulated PLD is still poorly understood. We now report
that oleate selectively stimulates the enzymatic activity of PLD2
but not of PLD1, with an optimal concentration of 20 WM in
vitro. Intriguingly, phosphatidylinositol 4,5-bisphosphate (PIP2)
synergistically stimulates the oleate-dependent PLD2 activity
with an optimal concentration of 2.5 WM. These results provide
the first evidence that oleate is a PLD2-specific activating factor
and PLD2 activity is synergistically stimulated by oleate and
PIP2.
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1. Introduction
Phospholipase D (PLD) catalyzes the hydrolysis of phos-
phatidylcholine (PC) to generate phosphatidic acid (PA) and
choline. PA has a number of biological activities including
direct regulation of a range of cell-speci¢c target proteins in
vitro [1^3]. PA can be further metabolized by PA phosphohy-
drolase to yield diacylglycerol which may function as an acti-
vator of protein kinase C (PKC) isoforms [4]. In the context
of these speci¢c roles, it has been proposed that PLD func-
tions in a variety of physiological processes including in£am-
mation, secretion, mitogenesis, neural and cardiac stimulation,
diabetes, and senescence [4].
Several factors were reported to stimulate PLD activity in
vitro. These include phosphatidylinositol 4,5-bisphosphate
(PIP2), monomeric GTP-binding proteins such as ADP-ribo-
sylation factor 1 (ARF1) and RhoA, and protein kinase C [1].
Hammond et al. [5] showed that the ¢rst cloned human PLD,
hPLD1, is regulated by PIP2, ARF, RhoA, and protein kinase
CK. The enzyme has low basal activity and is synergistically
activated by ARF1, RhoA, and PKCK in the presence of
PIP2. A second isoform of PLD, PLD2, was recently cloned
from mouse, rat, and human [6^8]. The PLD2s also essentially
require PIP2 for their enzymatic activities. They are constitu-
tively active in the presence of PIP2 [6]. Both PLD1 and PLD2
contain the pleckstrin-homology domain which can bind to
PIP2 [9]. Thus PIP2 has been implicated in PLD activation as
an essential PLD-activating factor [10].
In addition to the PIP2-dependent PLD isozymes, oleate-
dependent PLD activities have been reported by several re-
search groups [11^15]. Chalifour and Kanfer [11] identi¢ed an
oleate-dependent PLD activity in rat brain microsomes. The
enzyme is potently activated not only by oleate but also by
other unsaturated fatty acids including palmitoleate, linoleate,
and arachidonate. Okamura and Yamashita [14] puri¢ed an
oleate-dependent PLD with a molecular mass of 190 kDa
from pig lung membranes. Moreover, Massenburg et al. [15]
reported that the oleate-dependent PLD activity from rat
brain could be separated from the ARF-dependent PLD ac-
tivity by column chromatography. Despite these various re-
ports, the molecular structure and the characteristics of the
oleate-dependent PLD remained poorly understood.
In this study, we demonstrate for the ¢rst time that oleate
speci¢cally stimulates the enzymatic activity of PLD2, but not
of PLD1, and that it synergistically potentiates the PIP2-
stimulated activity of PLD2. The data suggest that unsatu-
rated fatty acids may play a role in the regulation of PLD2
in concert with PIP2.
2. Materials and methods
2.1. Materials
Dipalmitoylphosphatidyl[methyl-3H]choline was purchased from
Amersham International (Buckinghamshire, UK). PIP2, dipalmitoyl-
PC, dioleoyl-phosphatidylethanolamine (dioleoyl-PE), phosphatidyl-
serine (PS), phosphatidylinositol (PI), and fatty acids were purchased
from Sigma (St. Louis, MO, USA). L-Octylglucopyranoside was from
Calbiochem (San Diego, CA, USA). Chelating Sepharose resin was
from Amersham Pharmacia Biotech (Uppsala, Sweden).
2.2. Measurement of PLD activity
Oleate-dependent activity was assayed by a slightly modi¢ed pro-
cedure of Massenburg et al. [15]. PC vesicles (25 Wl) containing 5 nmol
of dipalmitoyl-PC and 200 000 dpm of dipalmitoylphosphatidyl[meth-
yl-3H]choline were added to reaction mixtures (175 Wl) containing
50 mM HEPES-NaOH (pH 7.0), 2 mM EGTA, 1.7 mM CaCl2,
20 WM sodium oleate, and 0.1 M KCl. The ¢nal concentration of
PC was 25 WM in the reaction mixtures. Assays were incubated at
30‡C for 1 h before adding 1 ml of CHCl3/CH3OH/concentrated HCl,
50:50:0.3 (v/v) and 0.3 ml of 1 M HCl/5 mM EGTA. After centrifu-
gation (5 min, 2000 rpm, 4‡C, Sorvall RC3B, H2000 B swinging
bucket rotor), [methyl-3H]choline in 0.5 ml of the aqueous phase
was quanti¢ed by liquid scintillation spectroscopy. PIP2-dependent
PLD activity was measured by choline release from PC essentially
as described [16].
2.3. Cell culture and preparation of the membrane fraction
U937 and L1210 cells were maintained in RPMI supplemented with
10% (v/v) bovine calf serum (HyClone), 100 units of penicillin/ml, and
100 mg of streptomycin/ml at 37‡C in a humidi¢ed, CO2-controlled
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(5%) incubator. The cells were centrifuged at 500Ug for 5 min into a
pellet, washed once with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, 1.8 mM KH2PO4, pH 7.4), and resuspended in ice-cold
hypotonic bu¡er (20 mM HEPES-NaOH (pH 7.5), 1 mM EGTA,
1 mM EDTA, 1 mM phenylmethylsulfonyl £uoride, 1 mM aprotinin,
2 mM leupeptin, 1 mM pepstatin). The cells were then disrupted by
sonication using an ultrasonicator (10-s burst; Branson Soni¢er 250,
Branson Ultrasonic Corp., Danbury, CT) and centrifuged at 500Ug
to remove intact cells. The cell homogenate was then centrifuged at
100 000Ug for 1 h using a TLA-100 ultracentrifuge to separate mem-
brane and cytosolic fractions. The membrane fractions was resus-
pended in the hypotonic bu¡er at a concentration of 2 mg protein/ml.
2.4. Immunoprecipitation and Western blotting
For immunoprecipitation, the membrane fractions of U937 and
L1210 cells were solubilized with ice-cold lysis bu¡er (20 mM
HEPES-NaOH (pH 7.5), 2% cholic acid, 1 mM EGTA, 1 mM
EDTA, 10 Wg/ml leupeptin, 10 Wg/ml aprotinin, and 1 mM phenyl-
methylsulfonyl £uoride) and precleared by centrifugation at 15 000Ug
for 10 min at 4‡C. Immunoprecipitations were performed by addition
of 30 Wl of protein A agarose (Pierce) which was coupled with 2 Wg
anti-PLD antibody as previously reported [17].
3. Results
3.1. Characterization of PLD isozymes in U937 and L1210
cells
We examined the cellular distribution of PLD1 and PLD2
in several cell lines including U937 promonocytic leukocytes
and L1210 lymphocytic leukemia cells by immunoprecipita-
tion of PLD isozymes and subsequent immunoblot analysis
using anti-PLD antibody which was raised against the C-ter-
minal dodecapeptide of hPLD1 as previously described [18].
The antibody speci¢cally recognizes both PLD1 and PLD2,
and we found that U937 and L1210 cells exclusively contained
PLD1 and PLD2, respectively (Fig. 1A). U937 cells have a
low PIP2-dependent PLD activity which can be stimulated up
to 10-fold by the addition of 1 WM ARF1 and 10 WM guano-
sine 5P-O-(3-thiotriphosphate) (GTPQS) in the presence of
PIP2 (Fig. 1B). On the other hand, L1210 cells have high
PIP2-dependent PLD activity which is not a¡ected by the
addition of ARF1 and GTPQS. These biochemical properties
of U937 and L1210 cells coincide with the properties of PLD1
and PLD2 as previously reported by Colley et al. [6].
In addition to the PIP2- or ARF1-stimulated PLD activ-
ities, the existence of an oleate-dependent PLD activity has
been suggested in various reports [11^15]. We looked for ole-
ate-dependent PLD activity in the absence of PIP2 and ARF1
and found that the membrane fraction of the L1210 cells in-
deed contained oleate-stimulated PLD activity (Fig. 1C). In
contrast, U937 cells did not show any oleate-stimulated PLD
activity. These results raised the possibility that PLD2 activity
may be stimulated by oleate.
3.2. Expression and a⁄nity puri¢cation of hPLD1 and hPLD2
hPLD1 and hPLD2 were expressed in a baculovirus expres-
sion system and puri¢ed from detergent extracts of baculovi-
Fig. 1. E¡ect of PIP2, ARF1, and oleate on the PLD activities of
U937 and L1210 cells. A: Immunoprecipitation of PLD isozymes
from U937 and L210 cells. Lysates (3 mg) of U937 and L1210 cells
were reacted with anti-PLD antibody, and the immune complexes
were subjected to SDS-PAGE followed by immunoblot analysis
with anti-PLD antibody. Data are representative of two separate ex-
periments. B: E¡ect of PIP2 and ARF1 on the PLD activities in
membrane fractions of U937 and L1210 cells. PIP2-dependent PLD
activities of U937 and L1210 cells were measured in the absence or
in the presence of 1 WM ARF1 and 10 WM GTPQS as indicated. Ali-
quots (10 Wg) of the membrane fractions were added to the reaction
mixtures containing substrate phospholipid vesicles (PE:PIP2 :PC,
16:1.4:1) and incubated at 37‡C for 15 min to measure choline-re-
leasing PLD activities as described in Section 2. C: E¡ect of oleate
on the PLD activities in membrane fractions of U937 and L1210
cells. Aliquots (10 Wg) of the membrane fractions were added to re-
action mixtures containing 25 WM PC in the absence (3) or the
presence (+) of 20 WM sodium oleate (OA), and were further incu-
bated at 30‡C for 1 h as described in Section 2. Data represent the
means þ S.D. from three di¡erent experiments.
Fig. 2. Analysis of puri¢ed hPLD1 and hPLD2 by SDS-PAGE and
Western blotting. Recombinant hPLD proteins were expressed by
baculovirus in Sf9 cells and a⁄nity-puri¢ed using chelating Sephar-
ose column chromatography. The puri¢ed 0.2 Wg hPLD1 (1) and
0.5 Wg hPLD2 (2) were subjected to SDS-PAGE followed by Coo-
massie brilliant blue staining (CBB) and Western blotting (I.B.) us-
ing anti-PLD antibody.
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rus-infected Sf9 cells using chelating Sepharose a⁄nity col-
umn chromatography as previously described [19]. From the
ten 150-mm dishes of Sf9 cells infected with recombinant ba-
culovirus we obtained about 20 Wg of hPLD1 and hPLD2,
respectively. The puri¢ed protein preparations were analyzed
by SDS-PAGE and Western blotting. As shown in Fig. 2,
hPLD1 and hPLD2 appeared to be puri¢ed to homogeneity
as estimated by the staining with Coomassie brilliant blue,
and the puri¢ed proteins were speci¢cally recognized by
anti-PLD antibody. The molecular masses of hPLD1 and
hPLD2 were estimated to be approximately 120 kDa and
100 kDa, respectively.
3.3. Selective activation of hPLD2 by oleate
In order to clarify whether PLD2 is speci¢cally activated by
oleate, we examined the e¡ect of sodium oleate on the enzy-
matic activity of puri¢ed hPLD1 and hPLD2 in the absence of
PIP2 and ARF1. As shown in Fig. 3, neither hPLD1 nor
PLD2 showed PLD activity in the absence of sodium oleate.
Intriguingly, hPLD2 was speci¢cally stimulated by the addi-
tion of sodium oleate. The optimal concentration of sodium
oleate was about 20 WM. In contrast, hPLD1 was not a¡ected
by the presence of sodium oleate.
3.4. E¡ect of fatty acids on PLD2 activity
The oleate-induced PLD2 activation may be due to a struc-
tural change in the substrate phospholipid vesicles caused by
oleate acting as a non-speci¢c detergent. To exclude this pos-
sibility, we next examined the e¡ect of other fatty acids on the
PLD activity and found that, in addition to oleate, other
unsaturated fatty acids including linoleate (18:2) and arach-
idonate (20:4) also stimulated PLD2 activity, while the satu-
rated fatty acids including myristate (14:0), palmitate (16:0),
stearate (18:0), and arachidate (20:0) were inactive (Fig. 4).
3.5. Synergistic activation of PLD2 by PIP2 and oleate
PIP2 has been described as an essential activating factor for
PLD2 activation [10]. To explore the e¡ect of PIP2 on the
requirement of oleate for PLD2 activation, we tested the e¡ect
of PIP2 on the oleate-dependent PLD2 activity. As shown in
Fig. 5A, PLD2 was maximally active in the presence of 2.5 WM
PIP2 in the absence of oleate. Intriguingly, PIP2 synergistically
stimulated PLD2 activity in the presence of 20 WM oleate. We
next examined the optimal concentration of sodium oleate for
PLD2 activation in the absence and presence of 2.5 WM PIP2.
Fig. 3. E¡ect of oleate on the PLD activities of hPLD1 and
hPLD2. Aliquots (5 ng) of puri¢ed hPLD1 and hPLD2 were as-
sayed for oleate-dependent PLD activity in the presence of the indi-
cated concentrations of sodium oleate at 30‡C for 1 h as described
in Section 2. Data represent the means þ S.D. from three di¡erent
experiments.
Fig. 4. E¡ect of fatty acids on the enzymatic activities of hPLD2.
Aliquots (5 ng) of hPLD2 were added to the reaction mixtures con-
taining the sodium salt form of indicated fatty acid at a ¢nal con-
centration of 20 WM as described in Fig. 3. Data represent the
mean þ S.D. from three di¡erent experiments.
Fig. 5. E¡ect of PIP2 on the oleate-dependent PLD activity. A: Ef-
fect of varying the concentration of PIP2 on the basal and oleate-
stimulated PLD2 activity. The amount of PIP2 was varied as indi-
cated while maintaining the amount of PC at 25 WM. Oleate-de-
pendent PLD2 activity was measured in the absence (3OA) or pres-
ence (+OA) of 20 WM sodium oleate as in Fig. 3. B: E¡ect of
varying the concentration of oleate on the PIP2-stimulated PLD ac-
tivity of PLD2. The amount of oleate was varied as indicated, and
the oleate-dependent PLD2 activity was measured in the absence
(3PIP2) or presence (+PIP2) of 2.5 WM PIP2. Data represent the
means þ S.D. from three di¡erent experiments.
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As shown in Fig. 5B, sodium oleate synergistically stimulated
PLD2 activity at an optimal concentration of 20 WM in the
presence of PIP2, suggesting that the synergistic activation of
PLD2 by PIP2 and oleate may be mediated by the speci¢c
interaction of PLD2 with PIP2 and oleate.
3.6. E¡ect of phospholipids on the oleate-dependent PLD
activity
PIP2 is an acidic phospholipid. Therefore it is tempting to
speculate that the PIP2-induced PLD2 activation could be
caused by a change in the surface charge or structure of the
substrate PC vesicles caused by the negative charge of PIP2.
In order to be able to exclude this possibility, we examined the
e¡ect of other phospholipids including PE, PS, and PI on the
oleate-dependent PLD2 activity. As shown in Fig. 6, the three
phospholipids had a small e¡ect on the oleate-dependent PLD
activity at 2.5 WM concentrations. PS and PI, the acidic phos-
pholipids, did not stimulate the oleate-dependent PLD2 activ-
ity as well as the basal PLD2 activity at concentrations rang-
ing from 0 to 25 WM (data not shown). This suggests that the
PIP2-induced PLD2 activation does not merely derive from
the change in structure and surface charge of the substrate PC
vesicles. In contrast, stearate, which is the corresponding
saturated fatty acid of oleate, did not stimulate the PIP2-de-
pendent activity of PLD2. Moreover, PLD1 activity was not
a¡ected by the addition of various concentrations of both
PIP2 and sodium oleate (data not shown).
4. Discussion
PLD2 has been known to be activated by PIP2, and the
PIP2-dependent activity of PLD2 is not a¡ected by PLD1-
activating factors such as ARF, small G proteins of the
Rho family, and PKC [6]. However, PIP2 is also essential
for PLD1 activation, thus it remained unclear how PLD2
activity is speci¢cally regulated. In the current study, for the
¢rst time, we show evidence that oleate is a PLD2-speci¢c
activating factor, and that the oleate-dependent activity of
PLD2 is synergistically up-regulated by PIP2.
The possibility that oleate may be acting as a non-speci¢c
detergent that changes the structure of the substrate phospho-
lipid vesicles enhancing PLD activity needed to be considered.
Alterations in the structure of the phospholipid vesicles may
a¡ect the access of PLD to the vesicles, thus apparently stim-
ulating PLD activity. However, this can be ruled out based on
the following ¢ndings. First, saturated fatty acids (Fig. 3) and
detergents including Triton X-100 and sodium cholate (data
not shown) were ine¡ective towards PLD2 activation, which is
in agreement with previous observations [12,20]. Second,
PLD2, but not PLD1, is speci¢cally stimulated by oleate.
The selective activation of PLD2 by oleate suggests that oleate
stimulates PLD2 activity through a speci¢c interaction with
PLD2 rather than acting as a non-speci¢c detergent on the
lipid vesicles.
An interesting ¢nding is the synergism between oleate and
PIP2 with respect to the PLD2 activation. In the present
study, we showed that 20 WM oleate and 2.5 WM PIP2 syner-
gistically stimulated the PLD2 activity. Oleate has been re-
ported to inhibit the PIP2-stimulated PLD2 activity [7,8] as
well as PLD1 activity stimulated by PIP2 and ARF [19,21].
However, we observed that at concentrations over 100 WM,
oleate strongly inhibits the PIP2-stimulated PLD2 activity and
is thus less e¡ective in PLD2 activation (data not shown),
consistent with the previous reports showing an inhibitory
e¡ect of oleate on PLD activities. Moreover, the basal and
oleate-stimulated PLD2 activities were optimally stimulated
by 2.5 WM PIP2, and concentrations higher than 5 WM PIP2
inhibited PLD2 activity (Fig. 5A), which is in agreement with
a previous report [22]. At high concentrations, PIP2 and ole-
ate may a¡ect the structure of substrate vesicles, therefore it is
possible to speculate that a structural alteration of the vesicles
may be the cause of the apparent inhibition of the enzymatic
activity of PLD2, and the molar ratios of oleate and PIP2
may, therefore, be critical for the synergistic activation of
PLD2.
PIP2 has been implicated as a PLD-activating factor essen-
tial for the activation of both PLD1 and PLD2. Both PLD
isozymes have the pleckstrin-homology domain which can
bind to PIP2 [9]. The interaction of the two PLD isozymes
with PIP2 helps in the access to the substrate vesicles contain-
ing PIP2 as previously reported [23]. Thus, the PLD2-speci¢c
activation by oleate raises the possibility that the PLD2 acti-
vation may be induced by direct interaction with oleate. It will
be necessary to ¢nd out whether PLD2 directly interacts with
oleate and which domain of PLD2 is implicated in this inter-
action.
Oleate and other unsaturated fatty acids have been pro-
posed to act as second messengers in signal transduction
[24]. Oleate and arachidonate regulate the activities of a great
number of signaling enzymes including PKC [25], guanylate
cyclase [26], Ca2-calmodulin-dependent kinase [27], and
phospholipase CQ1 [28]. In the present report we show evi-
dence that unsaturated fatty acids including oleate speci¢cally
up-regulate the PLD2 activity and synergistically stimulate
PLD2 activity in concert with PIP2. We are currently inves-
tigating whether the PLD2 activity is regulated by oleate and
PIP2 in cells in vivo.
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Fig. 6. E¡ect of phospholipids on the oleate-dependent PLD2 activ-
ity. PLD2 activity was measured in the absence (3) or presence (+)
of 20 WM oleate and 2.5 WM phospholipids, including PIP2, PE, PS,
and PI as in Fig. 5. As a control, 20 WM stearate and 2.5 WM PIP2
were added to the reaction mixture in the absence of oleate. Data
represent means þ S.D. from three di¡erent experiments.
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